Literature DB >> 15771858

[GETECCU-2005 recommendations for the use of infliximab (Remicade) in inflammatory bowel disease].

E Domènech1, M Esteve, F Gomollón, J Hinojosa, J Panés, A Obrador, M A Gassull.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15771858     DOI： 10.1157/13072012

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN： 0210-5705            Impact factor:   2.102


× No keyword cloud information.
  2 in total

Review 1.  Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.

Authors:  Pilar López-Serrano; Elsa de la Fuente Briongos; Elisa Carrera Alonso; Jose Lázaro Pérez-Calle; Conrado Fernández Rodríguez
Journal:  World J Hepatol       Date:  2015-03-27

2.  Tuberculin skin testing in inflammatory bowel disease patients from an endemic area of Brazil.

Authors:  Ingrid Puig Cardoso; Neogelia Pereira de Almeida; Daniela Rosa Gotardo; Mauricio Cardeal; Genoile Oliveira Santana
Journal:  Braz J Infect Dis       Date:  2013-09-20       Impact factor: 3.257
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.